ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0189

Racial Discrimination Among African American Women with and Without Systemic Lupus Erythematosus (SLE)

Jessica Browder1, Paula Ramos2, Diane Kamen2, Bethany Wolf2, S. Sam Lim3, Lori Ann Ueberroth2 and Lusawasra King2, 1Florida State University, Tallahassee, FL, 2Medical University of South Carolina, Charleston, SC, 3Emory University, Atlanta, GA

Meeting: ACR Convergence 2024

Keywords: Disparities, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Healthcare Disparities in Rheumatology Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Black or African American women are disproportionately affected by SLE but remain underrepresented in research studies. To further knowledge about this health disparity group, the goal of this study is to thoroughly investigate the relationship between discrimination and SLE disease outcomes in Black women with SLE.

Methods: Adult Black women meeting either the 1997 ACR revised criteria or the SLICC criteria for SLE, or without any connective tissue disease, were recruited for the Social Factors, Epigenomics and Lupus in African American Women (SELA) study. SLE disease activity was measured using the Systemic Lupus Activity Questionnaire (SLAQ), and SLE organ damage was measured using the Brief Index of Lupus Damage (BILD). Racial discrimination was measured using the Experiences of Discrimination (EOD) questionnaire, a validated multi-item measure used to assess experiences of racial discrimination. A Welch two sample t-test was computed for the associations between EOD and SLAQ, and a Wilcoxon rank sum test with continuity correction was computed for EOD and BILD. A linear model was also computed to test for association between EOD and log-transformed BILD, controlling for age. All analyses were performed on RStudio v4.0.3.

Results: This study enrolled 209 self-identified Black females, including 121 with SLE. The mean (±SD) age of SLE participants was 45.9±11.7 years, and the mean age of controls was 48.2±12.9 years. Among those with SLE, disease duration at the study visit was 17.1±8.8 years. Participant reported organ damage score measured by the BILD was 2.43 on average. Although some sociodemographic and behavioral characteristics were similar in patients and controls (e.g., 30% were married, 86% rarely or never drank), many other characteristics differed between the groups. Of controls, 89% reported experiencing racial discrimination, compared to 81% of SLE participants. No significant association was found between racial discrimination and SLE activity or organ damage after adjusting for age.

Conclusion: This study conducted in participants from South Carolina found higher rates of personal experiences with racial discrimination than a national survey,1 but similar to those reported in a previous study of Black women with SLE living in Atlanta, Georgia.2 Unlike this previous report,2 mean BILD score was significantly lower which may explain why the current study did not find associations between racial discrimination and SLE activity nor organ damage. Further investigation into environmental and socioeconomic differences between these communities that may affect SLE outcomes is warranted. Given the heterogeneity of Black communities, continued recruitment into this study and increased sample size is expected to enhance our knowledge about SLE in this population.

1Pew Research Center. On Views of Race and Inequality, Blacks and Whites Are Worlds Apart. June 27, 2016.

2Chae et al. Racial Discrimination, Disease Activity, and Organ Damage: The Black Women’s Experiences Living With Lupus (BeWELL) Study. Am J Epidemiol. 2019;188:1434-1443.


Disclosures: J. Browder: None; P. Ramos: None; D. Kamen: Alpine Immune Sciences, 1, Bristol Myers Squibb (BMS), 1; B. Wolf: None; S. Lim: Accordant, 2, AstraZeneca, 2, Biogen, 5, BMS, 5, Gilead, 5, GSK, 2, Novartis, 5, UCB, 5; L. Ueberroth: None; L. King: None.

To cite this abstract in AMA style:

Browder J, Ramos P, Kamen D, Wolf B, Lim S, Ueberroth L, King L. Racial Discrimination Among African American Women with and Without Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/racial-discrimination-among-african-american-women-with-and-without-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-discrimination-among-african-american-women-with-and-without-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology